IP Verse

Novartis Pharmaceuticals Corporation V. Msn Laboratories Private Limited - 1:25-cv-00081

Novartis Pharmaceuticals Corporation V. Msn Laboratories Private Limited (Case No. 1:25-cv-00081), filed on Jan 17, 2025 in the District Court, D. Delaware involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:25-cv-00081
Filing Date
Jan 17, 2025
Cause of Action
Patent Infringement
Status
OPEN
Court
District Court, D. Delaware
Nature of Suit
Patent

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Novartis Pharmaceuticals Corporation -
MSN Life Sciences Private Limited -
Novadoz Pharmaceuticals, LLC -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jun 17, 2025SO ORDERED, re MOTION for Pro Hac Vice Appearance of Attorney Shannon K. Clark filed by Novartis Pharmaceuticals Corporation (D.I. 64 in 1:25-cv-00081-RGA; D.I. 1898 in 1:20-md-02930-RGA). Signed by Judge Richard G. Andrews on 6/17/2025. (aas)PACER Document
Jun 17, 2025Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 6/17/2025. Local counsel for Plaintiff: A. Joyce. Local counsel for Defendants: R. Weinblatt. Plaintiff is to resubmit the final scheduling order by 6/23/2025.(Court Reporter Deanna Warner.) (aas)PACER Document
Jun 26, 2025PROPOSED Scheduling Order, by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) Modified on 6/26/2025 (nms). (Entered: 06/26/2025)PACER Document
Jun 26, 2025SCHEDULING ORDER: Joinder of Parties due by 2/17/2026. Amended Pleadings due by 2/17/2026. Fact Discovery completed by 3/27/2026. Dispositive Motions due by 10/2/2026. Answering Brief due 10/30/2026. Reply Brief due 11/13/2026. Joint Claim Construction Brief due by 11/25/2025. A Markman Hearing is set for 12/12/2025, at 9:30 AM in Courtroom 6A. A Pretrial Conference is set for 2/26/2027, at 9:30 AM in Courtroom 6A. A 5-day Jury Trial is set to start 3/8/2027, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 6/26/2025. Associated Cases: 1:20-md-02930-RGA, 1:25-cv-00081-RGA(nms) (Entered: 06/26/2025)PACER Document
Jun 27, 2025NOTICE OF SERVICE of (1) Novartis's Second Set of Interrogatories to MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, and Novadoz Pharmaceuticals, LLC (No. 8) and (2) Plaintiff's Infringement Contentions Against MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, and Novadoz Pharmaceuticals, LLC filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 06/27/2025)PACER Document
Jul 2, 2025PROPOSED Stipulated Protective Order, by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) Modified on 7/2/2025 (nms). (Entered: 07/02/2025)PACER Document
Jul 3, 2025SO ORDERED Granting (D.I. 70 in 25-cv-81-RGA; D.I. 1919 in 20-md-2930-RGA) Stipulated Protective Order. Signed by Judge Richard G. Andrews on 7/3/2025. Associated Cases: 1:20-md-02930-RGA, 1:25-cv-00081-RGA(nms) (Entered: 07/03/2025)PACER Document
Jul 7, 2025NOTICE OF SERVICE of (1) Plaintiff's Initial Paragraph 3 Disclosures Regarding Electronic Systems Information; and (2) Plaintiff's Rule 26(a)(1) Initial Disclosures filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 07/07/2025)PACER Document
Jul 7, 2025NOTICE OF SERVICE of (1) MSN Laboratories Private Limited s and MSN Pharmaceuticals Inc.s Initial Rule 26(a)(1) Disclosures and (2) MSN Laboratories Private Limiteds and MSN Pharmaceuticals Inc.s Initial ESI Disclosures filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 07/07/2025)PACER Document
Jul 28, 2025[SEALED] Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding Discovery Dispute. (Attachments: # 1 Certificate of Service, # 2 Exhibit 1-7)(Silver, Daniel) (Additional attachment(s) added on 7/29/2025: # 3 Proposed Order) (nms). (Entered: 07/28/2025)PACER Document
Jul 28, 2025NOTICE OF SERVICE of Defendants MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, and Novadoz Pharmaceuticals, LLCs First Responses to Plaintiffs Second Set of Interrogatories filed by MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc., Novadoz Pharmaceuticals, LLC.(Weinblatt, Richard) (Entered: 07/28/2025)PACER Document
Jul 28, 2025NOTICE OF SERVICE of Defendants MSN Pharmaceuticals Inc., MSN Laboratories Private Limited and MSN Life Sciences Private Limited, and Novadoz Pharmaceuticals, LLCs Invalidity Contentions Under Local Rules filed by MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc., Novadoz Pharmaceuticals, LLC.(Weinblatt, Richard) (Entered: 07/28/2025)PACER Document
Jul 29, 2025CORRECTING ENTRY: A proposed order has been added to D.I. 1948 in 20md2930-RGA, and D.I. 74 in 25cv81-RGA per counsel's request. The order was inadvertently omitted during original submission. Associated Cases: 1:25-cv-00081-RGA, 1:20-md-02930-RGA(nms)PACER Document
Jul 29, 2025Letter to The Honorable Richard G. Andrews, from Richard C. Weinblatt, in response to discovery dispute (D.I. 74 ). (Attachments: # 1 Proposed Order)(Weinblatt, Richard) Modified on 7/30/2025 (nms). (Entered: 07/29/2025)PACER Document
Jul 30, 2025ORDER: Plaintiff's discovery dispute (D.I. 1948 in 20-md-2930-RGA; D.I. 74 in 25-cv-81-RGA) is DISMISSED as moot. Signed by Judge Richard G. Andrews on 7/30/2025. Associated Cases: 1:20-md-02930-RGA, 1:25-cv-00081-RGA(nms) (Entered: 07/30/2025)PACER Document
Aug 4, 2025REDACTED VERSION of 74 Letter, by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (nms). Modified on 8/5/2025 (nms). (Entered: 08/04/2025)PACER Document
Aug 4, 2025NOTICE OF SERVICE of (1) Defendants MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, and Novadoz Pharmaceuticals, LLCs First Set of Interrogatories to Plaintiff Novartis Pharmaceuticals Corporation (Nos. 1-16) and (2) Defendants MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, MSN Life Sciences Private Limited and Novadoz Pharmaceuticals, LLCs First Set of Requests for Documents and Things (Nos. 1-64) to Plaintiff Novartis Pharmaceuticals Corporation filed by MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc., Novadoz Pharmaceuticals, LLC.(Weinblatt, Richard) (Entered: 08/04/2025)PACER Document
Aug 5, 2025CORRECTING ENTRY: A copy of the proposed order submitted with D.I. 74 has been added to the filing at D.I. 79 . (nms)PACER Document